Cellular and molecular life sciences : CMLS

IER3 may promote the progression from sepsis-related kidney injury to chronic kidney disease by blocking protective protein movement into mitochondria

Updated

Abstract

Essence

IER3 may drive sepsis-associated AKI toward CKD by blocking mitochondrial PRDX5 movement and promoting renal tubular cell senescence.

Evidence

Preclinical mouse and renal tubular cell experiments found that IER3 knockout reduced mortality, kidney injury, fibrotic repair, and stress-induced senescence after sepsis-associated AKI, while PRDX5 inhibition reversed these effects.

Caveat

The mechanistic evidence is mainly from preclinical models, with human relevance limited to prior single-cell expression patterns in AKI renal tubular cells.

Simplified

Key numbers

42%
Mortality Rate Decrease
Mortality rate in severe AKI cases.
2.6 million
AKI Cases Annually
Annual reported AKI cases in China.

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

0 of 7
authors report competing interests
7 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free